Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

Bektas Ö., ÜNER A., Eliacik E., Uz B., Isik A., Etgul S., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.33, no.2, pp.119-126, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.4274/tjh.2014.0455
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.119-126
  • Keywords: Myelodysplastic syndrome, International Prognostic Scoring System, MD Anderson Prognostic Scoring System, World Health Organization Classification-Based Prognostic Scoring System, Revised International Prognostic Scoring System, LEUKEMIC EVOLUTION, REFRACTORY-ANEMIA, CLASSIFICATION, RISK, VALIDATION, SURVIVAL, IMPACT, IPSS, MDS
  • Karadeniz Technical University Affiliated: No

Abstract

Objective: Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring systems have been developed. The aim of this study was to compare the different prognostic scoring systems.